7,224 results match your criteria Temporal Giant Cell Arteritis


Cytokines, growth factors and proteases in medium and large vessel vasculitis.

Clin Immunol 2019 Feb 14. Epub 2019 Feb 14.

Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, USA.

Giant cell arteritis and Takayasu arteritis are autoimmune vasculitides that cause aneurysm formation and tissue infarction. Extravascular inflammation consists of an intense acute phase response. Deeper understanding of pathogenic events in the vessel wall has highlighted the loss of tissue protective mechanisms, the intrusion of immune cells into "forbidden territory", and the autonomy of self-renewing vasculitic infiltrates. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2019.02.007DOI Listing
February 2019
1 Read

A probability score to aid the diagnosis of suspected giant cell arteritis.

Clin Exp Rheumatol 2019 Feb 15. Epub 2019 Feb 15.

Southend University Hospital NHS Trust, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK.

Objectives: We propose a GCA probability score intended to help to risk-stratify patients referred by general practitioners with suspected GCA into those with high probability of GCA versus low probability of GCA. In this pilot study we evaluated the diagnostic accuracy of this proposed scoring system.

Methods: A scoring system was proposed based on clinical experience. Read More

View Article

Download full-text PDF

Source
February 2019
6 Reads

Temporomandibular Disorder: An Important Cause of Temporal Headache in Patients Unlikely to Have Giant Cell Arteritis.

Semin Ophthalmol 2019 Feb 14:1-5. Epub 2019 Feb 14.

a Tennent Institute of Ophthalmology , Gartnavel General Hospital , Glasgow , UK.

Introduction: Temporal headache often results in an Ophthalmology referral to rule out giant cell arteritis (GCA). When clinical suspicion of GCA is low, alternative diagnoses should be considered. Temporomandibular disorder (TMD) commonly causes a temporal headache. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08820538.2019.1578383DOI Listing
February 2019

Massive B-Cell Infiltration and Organization Into Artery Tertiary Lymphoid Organs in the Aorta of Large Vessel Giant Cell Arteritis.

Front Immunol 2019 29;10:83. Epub 2019 Jan 29.

Department Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

Giant cell arteritis (GCA) can be classified into Cranial(C)-GCA and Large Vessel(LV)-GCA. Based on analysis of temporal arteries, GCA is postulated to be T-cell-mediated. Recently, a disturbed B-cell homeostasis was documented in newly diagnosed GCA patients. Read More

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fimmu.2019.00083
Publisher Site
http://dx.doi.org/10.3389/fimmu.2019.00083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361817PMC
January 2019
2 Reads

Should we biopsy temporal arteries to diagnose giant cell arteritis? A single-centre experience in Japan.

Scand J Rheumatol 2019 Feb 13:1-2. Epub 2019 Feb 13.

a Department of Internal Medicine , Tomakomai City Hospital , Tomakomai , Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03009742.2018.1563212DOI Listing
February 2019

and Co-infection in a Patient with Giant-cell Arteritis.

Eur J Case Rep Intern Med 2019 3;6(1):000997. Epub 2019 Jan 3.

Unidade Funcional de Medicina 2.1, Hospital de Santo António dos Capuchos, Centro Hospitalar de Lisboa Central, Lisbon, Portugal.

Immunosuppressed patients are at greater risk of unusual infections. The authors present the case of a woman with giant-cell arteritis, on oral steroids, who developed cavitating pneumonia due to co-infection with and . Reports of such co-infection are rare in the literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12890/2019_000997DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372051PMC
January 2019
1 Read

Giant-cell Arteritis of the Ovarian Arteries: A Rare Manifestation of a Common Disease.

Eur J Case Rep Intern Med 2018 25;5(5):000779. Epub 2018 May 25.

Department of Internal Medicine, Ikazia Ziekenhuis, Rotterdam, The Netherlands.

We describe a 58-year-old woman presenting with headache and an elevated erythrocyte sedimentation rate (ESR), who was diagnosed with and successfully treated for giant-cell arteritis (GCA). Seven months after the end of treatment, ovarian GCA was incidentally found after ovariectomy for a simple cyst. GCA of extracranial vessels like the ovarian arteries is rare. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12890/2018_000779DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346925PMC

Pulmonary nodules in a patient with Giant Cell Arteritis.

Pulmonology 2019 Feb 9. Epub 2019 Feb 9.

Internal Medicine Service, Centro Hospitalar Tondela-Viseu, E.P.E., Portugal. Electronic address:

Giant Cell Arteritis (GCA) is a common systemic vasculitis that involves medium and large arteries, most frequently extracranial branches of the carotid artery. Prompt diagnosis and treatment is essential to prevent devastating complications, such as blindness, stroke and aortic aneurysm or dissection. Typical symptoms include headache, temporal artery tenderness and jaw claudication. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pulmoe.2018.12.005DOI Listing
February 2019
1 Read

Shedding light on vasculitis in Egypt: a multicenter retrospective cohort study of characteristics, management, and outcome.

Clin Rheumatol 2019 Feb 9. Epub 2019 Feb 9.

Rheumatology and Rehabilitation Department, Faculty of Medicine, Assiut University, Assiut, Egypt.

Objectives: The frequency of different vasculitides and their characteristics vary among different regions. The identification of geographic disparities of disease phenotypes helps the development of international criteria, allowing the classification of patients of different ethnicities. This study aimed to describe the frequency, characteristics, course, response to treatment, and outcome of the different adulthood vasculitides in Egypt. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-019-04441-4DOI Listing
February 2019
1 Read

Ischemic stroke in giant-cell arteritis: French retrospective study.

J Autoimmun 2019 Feb 5. Epub 2019 Feb 5.

Service de Médecine Interne-DHU i2B, Hôpital Saint-Antoine, APHP, 75012, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, France. Electronic address:

Acute cerebrovascular ischemic events are a rare and severe complication of giant cell arteritis (GCA). We aimed to determine the prevalence of GCA-related stroke, the overall survival and the relapse-free survival in patients with GCA. A multicentric retrospective analysis was performed on 129 patients with GCA diagnosed between September 2010 and October 2018 in two University Hospitals. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08968411183073
Publisher Site
http://dx.doi.org/10.1016/j.jaut.2019.01.009DOI Listing
February 2019
4 Reads

The Treatment of Giant Cell Arteritis in Different Clinical Settings.

Front Immunol 2018 24;9:3129. Epub 2019 Jan 24.

Chugai Pharma Europe Ltd., Frankfurt am Main, Germany.

This paper aims to raise awareness of the different disease courses, comorbidities, and therapy situations in patients with giant cell arteritis (GCA), which require a differentiated approach and often a deviation from current treatment guidelines. With the approval of tocilizumab (TOC), which specifically binds to both soluble and membrane-bound IL-6 receptor and inhibits IL-6 receptor-mediated signaling, the spectrum of available effective treatment options has been significantly broadened. TOC yields an extensive range of possible applications that go beyond a glucocorticoid-saving effect. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.03129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353794PMC
January 2019
1 Read

Imaging in the management of giant cell arteritis.

Med Clin (Barc) 2019 Feb 4. Epub 2019 Feb 4.

Servicio de Enfermedades Autoinmunes, Hospital Clínic, Universitat de Barcelona, Barcelona, España.

Imaging has become an essential tool in the management of patients with giant cell arteritis. Cranial involvement detected by Doppler ultrasonography is an unquestionable diagnostic finding. Imaging of the aorta and its branches with positron emission tomography, computed tomography angiography or magnetic resonance imaging may also have a role in diagnosis and in the assessment of disease activity and response to treatment, but standardisation and validation are still needed before their widespread use as an outcome measure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2018.10.030DOI Listing
February 2019

Outcomes among 196 patients with non-infectious proximal aortitis.

Arthritis Rheumatol 2019 Feb 7. Epub 2019 Feb 7.

Division of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Objective: Non-infectious aortitis may occur in the context of a recognized systemic disease or as a topographically-limited lesion without systemic features, termed clinically-isolated aortitis (CIA). From a large population of patients in a single center dedicated to aortic diseases, we have sought to better define and stress the limitations of this diagnostic category, and suggest recommendations for care.

Methods: Records of patients undergoing thoracic aortic surgery (1996-2012) at the Cleveland Clinic were reviewed to identify 196 with histopathology-proven aortitis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40855DOI Listing
February 2019
3 Reads

[Giant cell arteritis of the vertebrobasilar system, posterior ischemia and palsy of the third nerve. Report of one case].

Rev Med Chil 2018 Nov;146(11):1356-1360

Departamento de Ciencias Neurológicas Oriente, Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Giant cell arteritis is the most common vasculitis in patients aged over 50 years. We report an 89-year-old woman with significant weight loss and persistent frontal-occipital headaches lasting two months. The neurological examination at admission identified a decrease in visual acuity of the left eye, paralysis of the third cranial nerve of the right eye and alterations of body motility without objective signs of damage of the motor or sensitive pathways. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4067/S0034-98872018001101356DOI Listing
November 2018
1 Read

Systematic Review of the Yield of Temporal Artery Biopsy for Suspected Giant Cell Arteritis.

Neuroophthalmology 2019 Feb 19;43(1):18-25. Epub 2018 Jun 19.

Harvard University Ophthalmology, Beth Israel Deaconness, Boston, Massachusetts, USA.

Purpose: To determine the positive yield (utility rate) of temporal artery biopsy (TAB) in patients with suspected giant cell arteritis (GCA).

Study Design: Systematic review (CRD42017078508) and meta-regression.

Materials And Methods: All articles concerning TAB for suspected GCA with English language abstracts from 1998 to 2017 were retrieved. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01658107.2018.1474372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351023PMC
February 2019
1 Read

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data.

Rheumatol Ther 2019 Feb 1. Epub 2019 Feb 1.

Genentech, Inc, South San Francisco, CA, USA.

Introduction: The safety profile of tocilizumab (TCZ) in patients with rheumatoid arthritis (RA) is well established. TCZ was approved to treat giant cell arteritis (GCA) in 2017 in the USA and Europe, and its safety profile in patients with GCA continues to be defined. The objective of this analysis was to examine incidence rates (IRs) of adverse events of special interest (AESI) occurring during the TCZ clinical development program and in healthcare claims data in patients with GCA or RA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40744-019-0139-5DOI Listing
February 2019
2 Reads

The modern therapy of systemic vasculitides: perspectives and challenges.

Ter Arkh 2018 Feb;90(1):76-85

Sechenov First Moscow State Medical University, Moscow, Russia.

Systemic vasculitis is a heterogeneous group of inflammatory diseases, which are classified according to the diameter of the affected vessels. The treatment of systemic vasculitis is no longer empirical, because of increasing number of randomized clinical trials in this field. In recent years, there was a trend to limit the cumulative dose of glucocorticosteroids and immunosuppressive drugs, partially through biological drugs usage. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26442/terarkh201890176-85DOI Listing
February 2018
1 Read

Takayasu arteritis: A distinct syndrome of large vessel vasculitis: A view point by late Professor Paul Bacon.

Authors:
Ramnath Misra

Int J Rheum Dis 2019 Jan;22 Suppl 1:49-52

Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.

Takayasu arteritis (TA), despite being classified as a large vessel vasculitis, has distinct genetic, pathological and clinical features as compared to giant cell arteritis. It is a rare disease seen more commonly in Asian countries. The challenge lies in assessing the degree of inflammation in a narrowed vessel and immunosuppressive therapy improves inflammatory features but is unable to open up an occluded vessel. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1756-185X.13383DOI Listing
January 2019
1 Read

Giant cell arteritis: early diagnosis is key.

Eye Brain 2019 17;11:1-12. Epub 2019 Jan 17.

Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA,

Giant cell arteritis (GCA) is an inflammatory vasculitis typically affecting elderly that can potentially cause vision loss. Studies have demonstrated that early recognition and initiation of treatment can improve visual prognosis in patients with GCA. This review addresses the benefits of early diagnosis and treatment, and discusses the available treatment options to manage the disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/EB.S170388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340646PMC
January 2019
1 Read

Pseudomonas meningoencephalitis masquerading as a stroke in a patient on tocilizumab.

BMJ Case Rep 2019 Jan 28;12(1). Epub 2019 Jan 28.

Box Hill Hospital, Box Hill, Victoria, Australia.

A previously high-functioning woman presents with clinical and CT features of a subacute ischaemic stroke. Her medical history is relevant for refractory giant cell arteritis on long-term high-dose prednisolone and recent commencement of tocilizumab (interleukin-6 monoclonal antibody). The potential for stroke mimic is considered and a magnetic resonance brain scan is requested. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2018-227296DOI Listing
January 2019
2 Reads

Diffuse large vessel giant cell arteritis found by Fluorodeoxyglucose PET/CT imaging.

Lancet 2019 01;393(10169):349

Cork University Hospital, Department of Medicine, University College Cork (Prof D O'Mahony), Cork, Ireland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)30117-5DOI Listing
January 2019
1 Read

Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases.

Prostate Cancer Prostatic Dis 2019 Jan 28. Epub 2019 Jan 28.

Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.

Background: Androgen deprivation therapy (ADT) has been a mainstay of treatment for advanced prostate cancer (PCa), but limited studies have been performed to investigate the association between ADT and autoimmune diseases.

Methods: We conducted a population-based nationwide cohort study of 17,168 patients newly diagnosed with PCa between 1996 and 2013 using the National Health Insurance Research Database (NHIRD) of Taiwan. Cox proportional hazards models with 1:1 propensity score-matched analysis were used to investigate the association between ADT use and the risk of autoimmune diseases. Read More

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41391-019-0130-9
Publisher Site
http://dx.doi.org/10.1038/s41391-019-0130-9DOI Listing
January 2019
6 Reads

Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosis.

Sci Rep 2019 Jan 24;9(1):688. Epub 2019 Jan 24.

Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Takayasu arteritis (TAK) and giant cell arteritis (GCA) are two major variants of large vessel vasculitis, and age is a major factor in their differential diagnosis. We sought to determine whether the two diseases exist on the same spectrum. We compared the serum levels of multiple cytokines and chemokines in 25 patients with TAK, 20 patients with GCA, and sex- and age-matched healthy donors for either condition (HD-TAK and HD-GCA). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-36825-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345929PMC
January 2019
2 Reads

New onset erythematous nodules in an elderly woman.

Dermatol Online J 2018 Aug 15;24(8). Epub 2018 Aug 15.

Harvard Medical School, Boston, Massachusetts.

An 86-year- old woman with a history of recurrent bronchitis and giant cell arteritis presented for new onset, cyclic and migratory erythematous nodules associated with fatigue and weight loss. Although a systemic vasculitis was initially suspected, elevated inflammatory markers and symptoms persisted despite aggressive corticosteroid therapy. Excisional biopsy of one nodule showed dense suppurative and granulomatous inflammation that was rife with acid-fast bacilli. Read More

View Article

Download full-text PDF

Source
August 2018
3 Reads

Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.

Ann Rheum Dis 2019 Jan 22. Epub 2019 Jan 22.

Department of Rheumatology, University Hospital Basel, Basel, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214704DOI Listing
January 2019
2 Reads
10.377 Impact Factor

Numerous Cotton Wool Spots From Giant Cell Arteritis.

J Clin Rheumatol 2019 Jan 18. Epub 2019 Jan 18.

From the Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000995DOI Listing
January 2019
3 Reads

Difference in immunohistochemical characteristics between Takayasu arteritis and giant cell arteritis: It may be better to distinguish them in the same age.

Mod Rheumatol 2019 Jan 21:1-10. Epub 2019 Jan 21.

a Department of Molecular Pathology , Tokyo Medical University , Tokyo , Japan.

Objectives: This study aimed to compare Takayasu arteritis (TAK) with giant cell arteritis (GCA) through immunohistochemistry principally of inflammatory cells; these two disorders may be on the spectrum within a single disease state.

Methods: Nine TAK and 5 GCA surgically resected vessel specimens were selected. TAK specimen was divided into each three acute-, chronic-, and healed-phase samples based on intimal and adventitial thickening. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14397595.2019.1570999DOI Listing
January 2019
1 Read

Autoimmune Diseases in Patients with Cushing's Syndrome after Resolution of Hypercortisolism: Case Reports and Literature Review.

Int J Endocrinol 2018 18;2018:1464967. Epub 2018 Dec 18.

Secondary Hypertension Unit, Department of Transactional Medicine and Precision, University of Rome "La Sapienza", Rome, Italy.

Introduction: Cushing's syndrome (CS) is a clinical condition characterized by excessive cortisol production, associated with metabolic complications, such as diabetes mellitus, dyslipidemia, metabolic syndrome, hypertension, and cardiovascular diseases. Nowadays, the occurrence of autoimmune diseases in CS have not been completely evaluated in the previous studies.

Objective: The aim of this study was to evaluate the occurrence of autoimmune diseases in CS patients after successfully treated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/1464967DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312625PMC
December 2018
8 Reads
1.515 Impact Factor

Giant Cell Arteritis Presenting with a Tongue Lesion-Diagnostic Dilemma.

Am J Med 2019 Jan 16. Epub 2019 Jan 16.

Department of Pathology, North Florida Regional Medical Center, Gainesville.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2018.12.026DOI Listing
January 2019
2 Reads

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.

Semin Arthritis Rheum 2019 Jan 5. Epub 2019 Jan 5.

Departments of Rheumatology, Internal Medicine and Pathology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Universidad de Cantabria, Santander, Spain. Electronic address:

Objective: Tocilizumab (TCZ) has shown efficacy in clinical trials on giant cell arteritis (GCA). Real-world data are scarce. Our objective was to assess efficacy and safety of TCZ in unselected patients with GCA in clinical practice Methods: Observational, open-label multicenter study from 40 national referral centers of GCA patients treated with TCZ due to inefficacy or adverse events of previous therapy. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00490172183057
Publisher Site
http://dx.doi.org/10.1016/j.semarthrit.2019.01.003DOI Listing
January 2019
4 Reads

Lesson of the month 2: When steroids stop working - infective endocarditis, the great mimicker.

Clin Med (Lond) 2019 Jan;19(1):82-84

Royal Sussex County Hospital, Brighton, UK.

A 63-year-old man with an extensive travel history to South East Asia presented with generalised malaise, temporal headaches and high inflammatory markers. He was treated with corticosteroids for presumed giant cell arteritis. Unsuccessful attempts to wean him from prednisolone prompted further investigations by rheumatology, haematology and finally ophthalmology. Read More

View Article

Download full-text PDF

Source
http://www.clinmed.rcpjournal.org/lookup/doi/10.7861/clinmed
Publisher Site
http://dx.doi.org/10.7861/clinmedicine.19-1-82DOI Listing
January 2019
12 Reads

Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.

J Rheumatol 2019 Jan 15. Epub 2019 Jan 15.

From the Mayo Clinic College of Medicine and Science, Department of Internal Medicine, Division of Rheumatology, and the Mayo Clinic College of Medicine, Department of Health Sciences Research, Rochester, Minnesota, USA; Division of Rheumatology, Azienda Ospedaliera, Unità Sanitaria Locale-Institute for Research and Health Care (USL-IRCCS) di Reggio Emilia e Università di Modena e Reggio Emilia, Modena e Reggio Emilia, Italy; Universidad Del Desarrollo, Clinica Alemana, Santiago, Chile. M.J. Koster, MD, Mayo Clinic College of Medicine and Science, Department of Internal Medicine, Division of Rheumatology; K. Yeruva, MD, Mayo Clinic College of Medicine and Science, Department of Internal Medicine, Division of Rheumatology; C.S. Crowson, PhD, Mayo Clinic College of Medicine and Science, Department of Internal Medicine, Division of Rheumatology, and the Mayo Clinic College of Medicine, Department of Health Sciences Research; F. Muratore, MD, Division of Rheumatology, Azienda Osedaliera, USL-IRCCS di Reggio Emilia e Università di Modena e Reggio Emilia; C. Labarca, MD, Universidad Del Desarrollo, Clinica Alemana; K.J. Warrington, MD, Mayo Clinic College of Medicine and Science, Department of Internal Medicine, Division of Rheumatology. Address correspondence to Dr. M.J. Koster, Mayo Clinic, 200 1st St. SW, Rochester, Minnesota 55905, USA. E-mail: Accepted for publication October 10, 2018.

Objective: To determine the effect of methotrexate (MTX) on relapse risk and glucocorticoid (GC) use in a large single-institution cohort of patients with giant cell arteritis (GCA).

Methods: Patients diagnosed with GCA from 1998 to 2013 with confirmed evidence of temporal artery biopsy and/or radiographic evidence of large vessel vasculitis were identified. Each patient with GCA treated with adjunct MTX (case) was matched to a similar patient with GCA treated only with GC (control). Read More

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180429
Publisher Site
http://dx.doi.org/10.3899/jrheum.180429DOI Listing
January 2019
7 Reads

Increased Incidence of Giant Cell Arteritis in Urban Areas?

J Rheumatol 2019 Jan 15. Epub 2019 Jan 15.

From the Hospital for Rheumatic Diseases, Haugesund, and Department of Clinical Science, University of Bergen, and Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease (BEaBIRD), Department of Rheumatology, Haukeland University Hospital, Bergen; Department of Clinical Science, University of Bergen, and BEaBIRD, Department of Rheumatology, Haukeland University Hospital, Bergen; Department of Rheumatology, Hospital of Southern Norway, Kristiansand, Norway. This study was supported by grants from the Norwegian Association of Heart and Lung Patients, the Norwegian Rheumatism Association, the Marit Hansens Memorial Fund, Merck Sharp & Dohme (MSD), and Odd Fellow Medical Research Fund. Address correspondence to Dr. L.K. Brekke, HSR AS, PB 2175, 5504 Haugesund, Norway. E-mail:

Giant cell arteritis (GCA) is the most common systemic vasculitis in adults. The pathogenesis and the etiology of the disease are not fully understood, and environmental factors, which may influence the incidence and prevalence, are poorly investigated. Only a few small studies have previously addressed the potential influence of rural or urban residence on the occurrence of GCA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180714DOI Listing
January 2019
3 Reads

The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis.

J Autoimmun 2019 Jan 9. Epub 2019 Jan 9.

Unit of Rheumatology, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy; Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Tuftsin-PhosphorylCholine (TPC) is a novel bi-specific molecule which links tuftsin and phosphorylcholine. TPC has shown immunomodulatory activities in experimental mouse models of autoimmune diseases. We studied herein the effects of TPC ex vivo on both peripheral blood mononuclear cells (PBMCs) and temporal artery biopsies (TABs) obtained from patients with giant cell arteritis (GCA) and age-matched disease controls. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08968411183054
Publisher Site
http://dx.doi.org/10.1016/j.jaut.2019.01.002DOI Listing
January 2019
5 Reads

Complete resolution of giant cell arteritis after tocilizumab monotherapy determined by positron emission tomography-CT.

BMJ Case Rep 2019 Jan 10;12(1). Epub 2019 Jan 10.

Department of Rheumatology, Kawasaki Medical School, Kurashiki, Japan.

View Article

Download full-text PDF

Source
http://casereports.bmj.com/lookup/doi/10.1136/bcr-2018-22869
Publisher Site
http://dx.doi.org/10.1136/bcr-2018-228697DOI Listing
January 2019
10 Reads

Endovascular treatment of critical lower limb ischemia caused by giant cell arteritis.

J Vasc Surg Cases Innov Tech 2019 Mar 7;5(1):31-34. Epub 2019 Jan 7.

Department of Vascular Surgery, Prince of Wales Hospital, Sydney, New South Wales, Australia.

Giant cell arteritis (GCA) is a well-known cause of cranial vasculitis often presenting with headache and jaw claudication. Here we report the case of a woman suffering GCA who presented with critical lower limb ischemia. Despite best medical therapy, she developed progressive calf claudication and ulceration of the right foot. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24684287183012
Publisher Site
http://dx.doi.org/10.1016/j.jvscit.2018.09.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322075PMC
March 2019
5 Reads

Performance characteristics and predictors of temporal artery ultrasound for the diagnosis of giant cell arteritis in routine clinical practice in a prospective cohort.

Clin Exp Rheumatol 2019 Jan 4. Epub 2019 Jan 4.

Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Dublin Academic Medical Centre, Dublin, Ireland.

Objectives: The diagnosis of giant cell arteritis (GCA) is primarily a clinical one. Temporal artery (TA) ultrasound (US) has been proposed as a new diagnostic tool. We aimed to assess the performance characteristics of TA US in routine clinical practice. Read More

View Article

Download full-text PDF

Source
January 2019
8 Reads

Seasonal incidence of biopsy-proven giant cell arteritis: a 20-year retrospective study of the University of California Davis Medical System.

Clin Exp Rheumatol 2019 Jan 7. Epub 2019 Jan 7.

Department of Ophthalmology, Roski Eye Institute, University of Southern California, Los Angeles, CA, and Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, UT, USA.

Objectives: Giant cell arteritis (GCA) is a vasculitis that affects large and medium sized arteries. The aetiology of GCA is unknown and numerous risk factors have been proposed. In this article, we evaluate the incidence of biopsy-positive GCA in Northern California and assess for seasonal variation. Read More

View Article

Download full-text PDF

Source
January 2019
9 Reads

Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study.

Clin Rheumatol 2019 Jan 7. Epub 2019 Jan 7.

Department of Internal Medicine and Clinical Immunology, Normandie Univ, UNICAEN, CHU de Caen Normandie, Avenue de la Côte de Nacre, 14000, Caen, France.

Introduction: Some studies suggest that there is an increased risk of malignancies in giant cell arteritis (GCA). We aimed to describe the clinical characteristics and outcomes of GCA patients with concomitant malignancy and compare them to a GCA control group.

Method: Patients with a diagnosis of GCA and malignancy and with a maximal delay of 12 months between both diagnoses were retrospectively included in this study and compared to a control group of age-matched (3:1) patients from a multicenter cohort of GCA patients. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10067-018-04407-y
Publisher Site
http://dx.doi.org/10.1007/s10067-018-04407-yDOI Listing
January 2019
6 Reads

A Rare Case of Takayasu Arteritis With Intracranial Involvement, Aortic Valvulitis, and Giant Cell Aortitis.

J Clin Rheumatol 2018 Dec 28. Epub 2018 Dec 28.

Department of Internal Medicine, Naval Medical Center San Diego, San Diego, CA Department of Neurology, Walter Reed National Military, Medical Center, Bethesda, MD Department of Radiology, Naval Medical Center San Diego, San Diego, CA Department of Internal Medicine/Rheumatology, Naval Medical Center San Diego, San Diego, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000960DOI Listing
December 2018
11 Reads

A subcutaneous fluid collection after the Bentall procedure in a female patient with giant cell arteritis.

Eur J Cardiothorac Surg 2018 Dec 27. Epub 2018 Dec 27.

Cardio-Thoracic and Vascular Surgery Department, Pontchaillou Hospital, Rennes, France.

We report a 61-year-old woman with a history of untreated inflammatory symptoms, who underwent a Bentall procedure for a rapidly evolving aneurysm. Postoperatively, she presented with a sub-sternal pulsatile mass communicating with a periaortic collection. After excluding surgical and infectious complications, an inflammatory seroma due to an uncontrolled vasculitis was suspected. Read More

View Article

Download full-text PDF

Source
https://academic.oup.com/ejcts/advance-article/doi/10.1093/e
Publisher Site
http://dx.doi.org/10.1093/ejcts/ezy432DOI Listing
December 2018
9 Reads

Response to: A Comparative Study of Doppler Ultrasound Against Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis.

Reumatol Clin 2018 Dec 23. Epub 2018 Dec 23.

Servicio de Reumatología, Hospital Universitario La Paz, Madrid, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reuma.2018.11.001DOI Listing
December 2018
2 Reads

A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility.

PLoS One 2018 26;13(12):e0209343. Epub 2018 Dec 26.

Instituto de Parasitología y Biomedicina "López-Neyra", CSIC, PTS Granada, Granada, Spain.

Background: The TNFSF13B (TNF superfamily member 13b) gene encodes BAFF, a cytokine with a crucial role in the differentiation and activation of B cells. An insertion-deletion variant (GCTGT→A) of this gene, leading to increased levels of BAFF, has been recently implicated in the genetic predisposition to several autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Based on the elevated levels of this cytokine found in patients with giant cell arteritis (GCA) and systemic sclerosis (SSc), we aimed to assess whether this functional variant also represents a novel genetic risk factor for these two disorders. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0209343PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306228PMC
December 2018
4 Reads
3.234 Impact Factor

Bilateral Optic Perineuritis as Initial Presentation of Giant Cell Arteritis.

Neurologist 2019 Jan;24(1):26-28

Hospital Italiano de Buenos Aires, Argentina.

Giant cell arteritis is a large vessel vasculitis with neurological manifestations that range from visual disturbances to ischemic stroke. Among the former, visual acuity and visual field defects are prevalent, with anterior ischemic optic neuropathy being their most frequent cause. We present a clinical case in which the presenting ocular feature of the disease was a peripheral monocular visual field defect secondary to optic perineuritis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NRL.0000000000000206DOI Listing
January 2019
3 Reads

Ascending Aortic Aneurysm Secondary to Isolated Noninfectious Ascending Aortitis.

J Clin Rheumatol 2018 Dec 5. Epub 2018 Dec 5.

Division of Rheumatology and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA.

Isolated noninfectious ascending aortitis (I-NIAA) is increasingly diagnosed at histopathologic review after resection of an ascending aortic aneurysm. PubMed was searched using the term aortitis; publications addressing the issue were reviewed, and reference lists of selected articles were also reviewed. Eleven major studies investigated the causes of an ascending aortic aneurysm or dissection requiring surgical repair: the prevalence of noninfectious aortitis ranged from 2% to 12%. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000948DOI Listing
December 2018
9 Reads

Main Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases.

J Clin Med 2018 Dec 25;8(1). Epub 2018 Dec 25.

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Internal Medicine, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, 20122 Milano, Italy.

Oral manifestations are frequent in patients with rheumatic diseases. The aim of this review is to offer readers practical advice concerning the onset, diagnosis and treatment of the main oral manifestations encountered in rheumatological and dental clinics. Signs and symptoms such as oral hyposalivation, xerostomia, temporomandibular joint disorders, periodontal disease, and dysphagia may be the first expression of a number of rheumatic diseases. Read More

View Article

Download full-text PDF

Source
http://www.mdpi.com/2077-0383/8/1/21
Publisher Site
http://dx.doi.org/10.3390/jcm8010021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351952PMC
December 2018
8 Reads

Giant cell arteritis related arteritic anterior ischemic optic neuropathy: Clinico-pathological correlation.

Indian J Ophthalmol 2019 Jan;67(1):142

Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijo.IJO_881_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324127PMC
January 2019
5 Reads

[Characteristics of giant cell arteritis patients under and over 75-years-old: A comparative study on 164 patients].

Rev Med Interne 2018 Dec 17. Epub 2018 Dec 17.

Aix-Marseille université, 13284 Marseille, France; Service de médecine interne et gériatrie, hôpital Nord, AP-HM, chemin des Bourrely, 13915 Marseille cedex 15, France.

Purpose: Giant cell arteritis (GCA) is the most common vasculitis of the elderly. In order to assess the impact of age at diagnosis, we compared the characteristics of patients of less than 75 years (<75 years), to those of the 75 years and over (≥75 years).

Patients And Methods: We conducted a retrospective study on 164 patients with GCA diagnosed from 2005 to 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.revmed.2018.11.004DOI Listing
December 2018
1 Read

Giant Cell Arteritis with Generalized Granuloma Annulare: A Case Report.

Intern Med 2018 Dec 18. Epub 2018 Dec 18.

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan.

We report the case of an 80-year-old man with generalized granuloma annulare (GGA) who subsequently developed giant cell arteritis (GCA). Steroid treatment was effective for both diseases in this case. Although cases of concomitant GGA and GCA have rarely been reported, previous studies suggest that common histological characteristics underlie the two diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.1978-18DOI Listing
December 2018
2 Reads